SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories - Quaterly Results

20 May 2025 Evaluate
An increase of about 88.90% to Rs. 577.70 millions in the topline was observed for the quarter ended March 2025. The topline stood at Rs. 305.83 millions during the similar quarter previous year.The Total Profit for the quarter ended March 2025 of Rs. 32.38 millions grew from Rs.-12.17 millions Operating profit Margin for the quarter ended March 2025 improved to 44.83% as compared to -20.27% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 577.70 305.83 88.90 1333.62 1820.52 -26.75 1333.62 1820.52 -26.75
Other Income 6.54 25.03 -73.87 54.28 96.82 -43.94 54.28 96.82 -43.94
PBIDT 44.83 -20.27 -321.16 7.53 12.73 -40.85 7.53 12.73 -40.85
Interest 0.55 0.21 161.90 1.75 0.78 124.36 1.75 0.78 124.36
PBDT 44.28 -20.48 -316.21 5.78 11.95 -51.63 5.78 11.95 -51.63
Depreciation 5.05 5.02 0.60 20.25 19.48 3.95 20.25 19.48 3.95
PBT 39.23 -25.50 -253.84 -14.47 -7.53 92.16 -14.47 -7.53 92.16
TAX 6.85 -13.33 -151.39 7.02 -10.93 -164.23 7.02 -10.93 -164.23
Deferred Tax 6.28 2.46 155.28 6.46 -1.11 -681.98 6.46 -1.11 -681.98
PAT 32.38 -12.17 -366.06 -21.49 3.40 -732.06 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 7.76 -6.63 -217.08 0.56 0.70 -19.26 0.56 0.70 -19.26

Valiant Laboratories Share Price

77.19 -4.06 (-5.00%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×